Grandhope, PKU build regenerative medicine institute, $48M VC fund
By Cornelia Zou
Wednesday, July 16, 2014
HONG KONG – A Guangzhou-based biotech company is working with one of the most prestigious universities in China to build a new institute and raise a fund to drive the development of stem cell and regenerative medicine projects.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.